Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.2 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |